Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-07-21 @ 7:30 AM
Study NCT ID:
NCT05609994
Status:
RECRUITING
Last Update Posted:
2025-07-18
First Post:
2022-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Sponsor:
Katy Peters, MD, PhD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Pro00108636
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |